To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers
Clinical trial NCT03651349 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03651349
- Sponsor
- Everfront Biotech Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2025-12-31
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.